鼻ポリープを伴う慢性鼻副鼻腔炎の世界市場レポート 2025年

鼻ポリープを伴う慢性鼻副鼻腔炎市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は9.0％で、62億1,000万米ドルに成長します。予測期間の成長は、生物学的療法の拡大、個別化医療の増加、技術進歩の進展、規制当局による承認の増加、患者中心の医療の拡大、疫学的動向のモニタリングなどに起因すると考えられます。予測期間における主な動向には、革新的なドラッグデリバリーシステム、病態生理学の理解、臨床試験、縦断的研究、認知度の向上、統合ケアモデル、有病率、発生率などが含まれます。

呼吸器疾患の有病率の上昇は、鼻ポリープを伴う慢性鼻副鼻腔炎市場の成長を促進すると予想されます。これらの疾患は、肺や気道などの呼吸器系に影響を及ぼし、大気汚染、喫煙、気候変動、感染症、職業性曝露、アレルギーなどの要因によって影響を受ける。喘息や慢性閉塞性肺疾患（COPD）などの疾患はますます一般的になっており、CRSwNPなどの関連疾患の罹患率上昇につながっています。この動向は、診断ツール、治療、外科的介入に対する需要に拍車をかけています。例えば、全米保健統計センター（NCHS）の最近のデータによると、米国成人の喘息有病率は2021年の8.4％から2022年には8.7％に増加し、喘息エピソードは同期間に3.3％から3.7％に増加しています。呼吸器感染症が蔓延するにつれて、鼻ポリープを伴う慢性鼻副鼻腔炎市場の成長はさらに刺激されると予想されます。

鼻ポリープを伴う慢性鼻副鼻腔炎市場の主要企業は、患者の転帰を改善し競争力を強化するために、抗IL-5生物学的製剤などの代替療法を優先しています。抗IL-5生物学的製剤は、重症の喘息や好酸球性疾患などの状態において好酸球性炎症を抑えることで標的治療を提供し、患者の症状コントロールとQOLを向上させる。例えば、2024年3月、革新的な製品の開発・商業化に注力する米国の製薬会社Optinose社は、成人の慢性鼻副鼻腔炎（CRS）を適応症とする処方箋点鼻薬XHANCEの米国食品医薬品局（FDA）承認を取得しました。鼻腔の炎症を抑えるコルチコステロイドであるフルチカゾンプロピオン酸エステルを含有しています。主な特徴は、独自の呼気デリバリーシステム（EDS）であり、患者はスプレーを投与しながら装置に向かって息を吐くことができ、これにより鼻腔の奥深くへの薬物送達が強化され、鼻ポリープが形成され副鼻腔から排出される部分を効果的にターゲットとします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界鼻ポリープを伴う慢性鼻副鼻腔炎PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の鼻ポリープを伴う慢性鼻副鼻腔炎市場：成長率分析
• 世界の鼻ポリープを伴う慢性鼻副鼻腔炎市場の実績：規模と成長, 2019-2024
• 世界の鼻ポリープを伴う慢性鼻副鼻腔炎市場の予測：規模と成長, 2024-2029, 2034F
• 世界鼻ポリープを伴う慢性鼻副鼻腔炎総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の鼻ポリープを伴う慢性鼻副鼻腔炎市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品
• 手術方法
• 世界の鼻ポリープを伴う慢性鼻副鼻腔炎市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鼻腔
• オーラル
• その他の投与経路
• 世界の鼻ポリープを伴う慢性鼻副鼻腔炎市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の鼻ポリープを伴う慢性鼻副鼻腔炎市場、医薬品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• コルチコステロイド（点鼻スプレー、経口ステロイド）
• 生物学的製剤（デュピルマブのようなモノクローナル抗体）
• 抗生物質
• 抗ヒスタミン薬
• ロイコトリエン修飾薬
• 世界の鼻ポリープを伴う慢性鼻副鼻腔炎市場、手術方法の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 内視鏡下副鼻腔手術（ESS）
• ポリープ切除術（ポリープ除去）
• バルーンサイナプラシー

第7章 地域別・国別分析

• 世界の鼻ポリープを伴う慢性鼻副鼻腔炎市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の鼻ポリープを伴う慢性鼻副鼻腔炎市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 鼻ポリープを伴う慢性鼻副鼻腔炎市場：競合情勢
• 鼻ポリープを伴う慢性鼻副鼻腔炎市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co Inc Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Novartis AG
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Medtronic plc
• Boehringer Ingelheim International GmbH
• Amgen Inc
• Teva Pharmaceutical Industries Ltd
• Regeneron Pharmaceuticals Inc
• Daiichi Sankyo Company Limited
• Olympus Corporation
• Eisai Co Ltd
• Smith & Nephew PLC
• Genentech USA Inc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 鼻ポリープを伴う慢性鼻副鼻腔炎市場2029：新たな機会を提供する国
• 鼻ポリープを伴う慢性鼻副鼻腔炎市場2029：新たな機会を提供するセグメント
• 鼻ポリープを伴う慢性鼻副鼻腔炎市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is an enduring inflammatory condition affecting the sinuses and nasal passages, characterized by the development of nasal polyps. These polyps are benign, swollen tissues that form in response to ongoing inflammation in the nasal passages or sinuses. Diagnosis typically involves evaluating symptoms, conducting clinical examinations, utilizing imaging techniques, allergy tests, and occasionally performing biopsies.

The primary treatments for chronic rhinosinusitis with nasal polyps encompass both pharmaceutical and surgical approaches. Medications aim to alleviate inflammation, manage symptoms, and reduce the size of polyps. They can be administered via nasal sprays, orally, or through other routes, and are available through hospital pharmacies, retail outlets, and online platforms.

The chronic rhinosinusitis with nasal polyps market research report is one of a series of new reports from the business research company that provides chronic rhinosinusitis with nasal polyps market statistics, including chronic rhinosinusitis with nasal polyps industry global market size, regional shares, competitors with an chronic rhinosinusitis with nasal polyps market share, detailed chronic rhinosinusitis with nasal polyps market segments, market trends and opportunities, and any further data you may need to thrive in the chronic rhinosinusitis with nasal polyps industry. This chronic rhinosinusitis with nasal polyps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chronic rhinosinusitis with nasal polyps market size has grown strongly in recent years. It will grow from $4.02 billion in 2024 to $4.4 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing prevalence, growing advancements in diagnosis, increasing treatment innovation, growing patient awareness, and increasing healthcare spending.

The chronic rhinosinusitis with nasal polyps market size is expected to see strong growth in the next few years. It will grow to $6.21 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to growing biologic therapies, increasing personalized medicine, advancing technological advancements, increasing regulatory approvals, growing patient-centric care, and monitoring epidemiological trends. Major trends in the forecast period include innovative drug delivery systems, understanding pathophysiology, clinical trials, longitudinal studies, increased awareness, integrated care models, prevalence, and incidence.

The rising prevalence of respiratory diseases is expected to drive growth in the chronic rhinosinusitis with nasal polyps market. These diseases affect the respiratory system, including the lungs and airways, and are influenced by factors such as air pollution, smoking, climate change, infections, occupational exposures, and allergies. Conditions such as asthma and chronic obstructive pulmonary disease (COPD) are increasingly common, leading to higher rates of associated conditions such as CRSwNP. This trend is fueling demand for diagnostic tools, treatments, and surgical interventions. For example, recent data from the National Center for Health Statistics (NCHS) shows an increase in asthma prevalence among U.S. adults from 8.4% in 2021 to 8.7% in 2022, with asthma episodes rising from 3.3% to 3.7% over the same period. As respiratory tract infections become more prevalent, they are expected to further stimulate growth in the chronic rhinosinusitis with nasal polyps market.

Leading companies in the chronic rhinosinusitis with nasal polyps market are prioritizing alternative therapies, such as anti-IL-5 biologics, to improve patient outcomes and strengthen their competitive edge. Anti-IL-5 biologics provide targeted treatment by reducing eosinophilic inflammation in conditions like severe asthma and eosinophilic disorders, enhancing symptom control and quality of life for patients. For instance, in March 2024, Optinose, a U.S.-based pharmaceutical company focused on developing and commercializing innovative products, received U.S. Food and Drug Administration (FDA) approval for XHANCE, a prescription nasal spray indicated for chronic rhinosinusitis (CRS) in adults, including both chronic rhinosinusitis with nasal polyps (CRSwNP) and without nasal polyps (CRSsNP). It contains fluticasone propionate, a corticosteroid that reduces nasal passage inflammation. A key feature is its unique Exhalation Delivery System (EDS), enabling patients to exhale into the device while administering the spray, which enhances medication delivery deep into the nasal passages, effectively targeting areas where nasal polyps form and sinuses drain.

In May 2022, Medtronic Plc, a US-based medical technology solutions company, completed the acquisition of Intersect ENT Inc. for an undisclosed amount. The acquisition adds Intersect ENT's PROPEL and SINUVA sinus implant product lines and technology to Medtronic's existing ear, nose, and throat (ENT) portfolio. Intersect ENT Inc. is a US-based medical technology company specializing in treating chronic rhinosinusitis with nasal polyps.

Major companies operating in the chronic rhinosinusitis with nasal polyps market are Pfizer Inc., Roche Holding AG, Merck & Co Inc, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Medtronic plc, Boehringer Ingelheim International GmbH, Amgen Inc, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc, Daiichi Sankyo Company Limited, Olympus Corporation, Eisai Co Ltd, Smith & Nephew PLC, Genentech USA Inc, Mallinckrodt Pharmaceuticals, Lyra Therapeutics Inc, Sunovion Pharmaceuticals, Acclarent Inc., Optinose US Inc, SinuSys Corporation, Biohaven Pharmaceuticals

North America was the largest region in the chronic rhinosinusitis with nasal polyps market in 2024. The regions covered in the chronic rhinosinusitis with nasal polyps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chronic rhinosinusitis with nasal polyps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic rhinosinusitis with nasal polyps market consists of revenues earned by entities by providing services such as medical consultations, diagnostic procedures, pharmacological treatments, and surgical interventions. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic rhinosinusitis with nasal polyps market also includes sales of nasal corticosteroid sprays, antihistamines, saline nasal sprays, and devices for nasal irrigation, as well as surgical instruments and equipment used in procedures such as polypectomy and functional endoscopic sinus surgery. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Rhinosinusitis With Nasal Polyps Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic rhinosinusitis with nasal polyps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic rhinosinusitis with nasal polyps ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic rhinosinusitis with nasal polyps market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Medications; Surgical Methods
• 2) By Route Of Administration: Nasal; Oral; Other Routes Of Administration
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Medications: Corticosteroids (Nasal Sprays, Oral Steroids); Biologics (Monoclonal Antibodies Like Dupilumab); Antibiotics; Antihistamines; Leukotriene Modifiers
• 2) By Surgical Methods: Endoscopic Sinus Surgery (ESS); Polypectomy (Polyps Removal); Balloon Sinuplasty
• Companies Mentioned: Pfizer Inc.; Roche Holding AG; Merck & Co Inc; Bayer AG; Sanofi SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chronic Rhinosinusitis With Nasal Polyps Market Characteristics

3. Chronic Rhinosinusitis With Nasal Polyps Market Trends And Strategies

4. Chronic Rhinosinusitis With Nasal Polyps Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Chronic Rhinosinusitis With Nasal Polyps Growth Analysis And Strategic Analysis Framework

• 5.1. Global Chronic Rhinosinusitis With Nasal Polyps PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Chronic Rhinosinusitis With Nasal Polyps Market Growth Rate Analysis
• 5.4. Global Chronic Rhinosinusitis With Nasal Polyps Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Chronic Rhinosinusitis With Nasal Polyps Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Chronic Rhinosinusitis With Nasal Polyps Total Addressable Market (TAM)

6. Chronic Rhinosinusitis With Nasal Polyps Market Segmentation

• 6.1. Global Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications
• Surgical Methods
• 6.2. Global Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nasal
• Oral
• Other Routes Of Administration
• 6.3. Global Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Chronic Rhinosinusitis With Nasal Polyps Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids (Nasal Sprays, Oral Steroids)
• Biologics (Monoclonal Antibodies Like Dupilumab)
• Antibiotics
• Antihistamines
• Leukotriene Modifiers
• 6.5. Global Chronic Rhinosinusitis With Nasal Polyps Market, Sub-Segmentation Of Surgical Methods, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endoscopic Sinus Surgery (ESS)
• Polypectomy (Polyps Removal)
• Balloon Sinuplasty

7. Chronic Rhinosinusitis With Nasal Polyps Market Regional And Country Analysis

• 7.1. Global Chronic Rhinosinusitis With Nasal Polyps Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Chronic Rhinosinusitis With Nasal Polyps Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chronic Rhinosinusitis With Nasal Polyps Market

• 8.1. Asia-Pacific Chronic Rhinosinusitis With Nasal Polyps Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chronic Rhinosinusitis With Nasal Polyps Market

• 9.1. China Chronic Rhinosinusitis With Nasal Polyps Market Overview
• 9.2. China Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chronic Rhinosinusitis With Nasal Polyps Market

• 10.1. India Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chronic Rhinosinusitis With Nasal Polyps Market

• 11.1. Japan Chronic Rhinosinusitis With Nasal Polyps Market Overview
• 11.2. Japan Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chronic Rhinosinusitis With Nasal Polyps Market

• 12.1. Australia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chronic Rhinosinusitis With Nasal Polyps Market

• 13.1. Indonesia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chronic Rhinosinusitis With Nasal Polyps Market

• 14.1. South Korea Chronic Rhinosinusitis With Nasal Polyps Market Overview
• 14.2. South Korea Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chronic Rhinosinusitis With Nasal Polyps Market

• 15.1. Western Europe Chronic Rhinosinusitis With Nasal Polyps Market Overview
• 15.2. Western Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chronic Rhinosinusitis With Nasal Polyps Market

• 16.1. UK Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chronic Rhinosinusitis With Nasal Polyps Market

• 17.1. Germany Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chronic Rhinosinusitis With Nasal Polyps Market

• 18.1. France Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chronic Rhinosinusitis With Nasal Polyps Market

• 19.1. Italy Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chronic Rhinosinusitis With Nasal Polyps Market

• 20.1. Spain Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chronic Rhinosinusitis With Nasal Polyps Market

• 21.1. Eastern Europe Chronic Rhinosinusitis With Nasal Polyps Market Overview
• 21.2. Eastern Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chronic Rhinosinusitis With Nasal Polyps Market

• 22.1. Russia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chronic Rhinosinusitis With Nasal Polyps Market

• 23.1. North America Chronic Rhinosinusitis With Nasal Polyps Market Overview
• 23.2. North America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chronic Rhinosinusitis With Nasal Polyps Market

• 24.1. USA Chronic Rhinosinusitis With Nasal Polyps Market Overview
• 24.2. USA Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chronic Rhinosinusitis With Nasal Polyps Market

• 25.1. Canada Chronic Rhinosinusitis With Nasal Polyps Market Overview
• 25.2. Canada Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chronic Rhinosinusitis With Nasal Polyps Market

• 26.1. South America Chronic Rhinosinusitis With Nasal Polyps Market Overview
• 26.2. South America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chronic Rhinosinusitis With Nasal Polyps Market

• 27.1. Brazil Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chronic Rhinosinusitis With Nasal Polyps Market

• 28.1. Middle East Chronic Rhinosinusitis With Nasal Polyps Market Overview
• 28.2. Middle East Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chronic Rhinosinusitis With Nasal Polyps Market

• 29.1. Africa Chronic Rhinosinusitis With Nasal Polyps Market Overview
• 29.2. Africa Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chronic Rhinosinusitis With Nasal Polyps Market Competitive Landscape And Company Profiles

• 30.1. Chronic Rhinosinusitis With Nasal Polyps Market Competitive Landscape
• 30.2. Chronic Rhinosinusitis With Nasal Polyps Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

31. Chronic Rhinosinusitis With Nasal Polyps Market Other Major And Innovative Companies

• 31.1. Bristol-Myers Squibb Company
• 31.2. AstraZeneca PLC
• 31.3. Novartis AG
• 31.4. GlaxoSmithKline plc
• 31.5. Takeda Pharmaceutical Company Limited
• 31.6. Medtronic plc
• 31.7. Boehringer Ingelheim International GmbH
• 31.8. Amgen Inc
• 31.9. Teva Pharmaceutical Industries Ltd
• 31.10. Regeneron Pharmaceuticals Inc
• 31.11. Daiichi Sankyo Company Limited
• 31.12. Olympus Corporation
• 31.13. Eisai Co Ltd
• 31.14. Smith & Nephew PLC
• 31.15. Genentech USA Inc

32. Global Chronic Rhinosinusitis With Nasal Polyps Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Rhinosinusitis With Nasal Polyps Market

34. Recent Developments In The Chronic Rhinosinusitis With Nasal Polyps Market

35. Chronic Rhinosinusitis With Nasal Polyps Market High Potential Countries, Segments and Strategies

• 35.1 Chronic Rhinosinusitis With Nasal Polyps Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Chronic Rhinosinusitis With Nasal Polyps Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Chronic Rhinosinusitis With Nasal Polyps Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer